maltohexaose has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auger, KD; Brewer, MK; Bridges, TM; Chakravarthy, S; Dukhande, VV; Gentry, MS; Hellman, LM; Hsu, S; Husodo, S; Li, S; Meekins, DA; Paasch, BC; Parker, MW; Raththagala, M; Sanz, P; Sherwood, AR; Taylor, AO; Turner, BD; Vander Kooi, CW; Wong, BK; Woods, VL | 1 |
1 other study(ies) available for maltohexaose and Epilepsy Progressive Myoclonic 2
Article | Year |
---|---|
Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.
Topics: Catalytic Domain; Crystallography, X-Ray; Glycogen; Humans; Lafora Disease; Models, Molecular; Oligosaccharides; Phosphates; Phosphorylation; Protein Binding; Protein Multimerization; Protein Structure, Secondary; Protein Tyrosine Phosphatases, Non-Receptor | 2015 |